Immatics Competitors and Similar CompaniesClear all

Immatics's competitors and similar companies include Eureka Therapeutics and Juno Therapeutics.

	Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.	Eureka Therapeutics Eureka Therapeutics is a biotechnology company focused on discovery of novel antibody immunotherapies for the treatment of cancer.	Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer.
Founding Date	Founding Date N/A	Founding Date 2006	Founding Date 2013
Type	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech pharma therapy	Tags Healthcare bioengineering drug development oncology therapy	Tags Healthcare biotech clinics pharma platform
Locations	Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US	Locations Emeryville, US HQ	Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US
Employees	Employees 29723% increase	Employees 432% decrease	Employees 1091% decrease
Financial
Revenue (est.)	Revenue (est.) €48.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $111.9m (FY, 2017)
Net income	Net income (€196.4m) (FY, 2025)	Net income N/A	Net income ($437.1m) (FY, 2017)
Funding
Total funding raised	Total funding raised $ 267.3m	Total funding raised $ 130.4m	Total funding raised $ 310m